Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction-Reference-Cited by-同舟云学术

Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction

Published:2020-05 Issue:5 Volume:8 Page:372-381
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Cunningham Jonathan W.,Vaduganathan Muthiah,Claggett Brian L.,Zile Michael R.,Anand Inder S.,Packer Milton,Zannad Faiez,Lam Carolyn S.P.,Janssens Stefan,Jhund Pardeep S.,Kober Lars,Rouleau Jean,Shah Sanjiv J.,Chopra Vijay K.,Shi Victor C.,Lefkowitz Martin P.,Prescott Margaret F.,Pfeffer Marc A.,McMurray John J.V.,Solomon Scott D.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. Evolution of natriuretic peptide biomarkers in heart failure: implications for clinical care and clinical trials;Vodovar;Int J Cardiol,2018

2. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP study;Januzzi;Eur Heart J,2005

3. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT);Anand;Circulation,2003

4. Effect of neprilysin inhibition on various natriuretic peptide assays;Ibrahim;J Am Coll Cardiol,2019

5. B-type natriuretic peptide during treatment with sacubitril/valsartan. the PARADIGM-HF trial;Myhre;J Am Coll Cardiol,2019

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-hospital initiation of angiotensin receptor–neprilysin inhibition in acute heart failure: the PREMIER trial;European Heart Journal;2024-08-31

2. Biomarkers in Heart Failure with Preserved Ejection Fraction: A Perpetually Evolving Frontier;Journal of Clinical Medicine;2024-08-07

3. Sacubitril/valsartan and cardiovascular biomarkers among patients with recent COVID‐19 infection: The PARACOR‐19 randomized clinical trial;European Journal of Heart Failure;2024-05-11

4. Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection Fraction;JAMA Cardiology;2024-05-01

5. Angiotensin–Neprilysin inhibition in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials;Current Problems in Cardiology;2024-01